Patents by Inventor Naohiro Inohara
Naohiro Inohara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230364162Abstract: Provided herein are compositions and methods for the management of intestinal inflammation. In particular, compositions comprising modified adherent-invasive E. coli (AIEC) are administered to human and/or animal subjects to treat, prevent or decrease susceptibility to intestinal inflammation.Type: ApplicationFiled: September 28, 2021Publication date: November 16, 2023Inventors: Masashi Ohno, Gabriel Nunez, Naohiro Inohara, Mizuho Hasegawa
-
Publication number: 20090035851Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod1 protein. The present invention provides methods of identifying modulators of Nod1 signaling. The present invention further provides methods of altering Nod1 signaling.Type: ApplicationFiled: March 31, 2008Publication date: February 5, 2009Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, OSAKA UNIVERSITYInventors: Naohiro Inohara, Koichi Fukase, Yukari Fujimoto
-
Publication number: 20080280367Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides methods of screening immune modulators such as adjuvants using Nod2. The present invention further provides methods of altering Nod2 signaling.Type: ApplicationFiled: March 26, 2008Publication date: November 13, 2008Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura
-
Patent number: 7375086Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides methods of screening immune modulators such as adjuvants using Nod2. The present invention further provides methods of altering Nod2 signaling.Type: GrantFiled: January 12, 2006Date of Patent: May 20, 2008Assignee: The Regents of the University of MichiganInventors: Gabriel Nuñez, Naohiro Inohara, Yasunori Ogura
-
Patent number: 7244557Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod1 protein. The present invention provides methods of identifying modulators of Nod1 signaling. The present invention further provides methods of altering Nod1 signaling.Type: GrantFiled: May 14, 2004Date of Patent: July 17, 2007Assignee: Regents of the University of MichiganInventors: Gabriel Nuñez, Naohiro Inohara
-
Patent number: 7176019Abstract: The present invention related to methods and compositions for modulating cellular signaling. In particular, the present invention relates to PKK and RICK3 proteins. The present invention further relates the to use of PKK and RICK3 proteins in modulating NF-?B signaling. The present invention thus provides novel targets for drug screening and therapeutics.Type: GrantFiled: December 22, 2005Date of Patent: February 13, 2007Assignee: The Regents of the University of MichiganInventors: Gabriel Nuñez, Naohiro Inohara, Akihiro Muto
-
Publication number: 20060292590Abstract: The present invention relates to the NOD proteins and nucleic acids encoding the NOD proteins. The present invention further provides assays for the detection of NOD polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NOD proteins.Type: ApplicationFiled: January 26, 2006Publication date: December 28, 2006Inventors: Naohiro Inohara, Gabriel Nunez
-
Publication number: 20060258580Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod1 protein. The present invention provides methods of identifying modulators of Nod1 signaling. The present invention further provides methods of altering Nod1 signaling.Type: ApplicationFiled: October 13, 2005Publication date: November 16, 2006Applicants: Regents of the University of Michigan, Osaka UniversityInventors: Naohiro Inohara, Koichi Fukase, Yukari Fujimoto
-
Publication number: 20060160118Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides methods of screening immune modulators such as adjuvants using Nod2. The present invention further provides methods of altering Nod2 signaling.Type: ApplicationFiled: January 12, 2006Publication date: July 20, 2006Inventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura
-
Patent number: 7060493Abstract: The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, methods for the detection of Nod2, and methods for screening compounds for the ability to alter Nod2 associated signal transduction.Type: GrantFiled: November 9, 2004Date of Patent: June 13, 2006Assignee: Regents of the University of MichiganInventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura
-
Patent number: 7060442Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides methods of screening immune modulators such as adjuvants using Nod2. The present invention further provides methods of altering Nod2 signaling.Type: GrantFiled: December 9, 2002Date of Patent: June 13, 2006Assignee: Regents of the University of MichiganInventors: Gabriel Nuñez, Naohiro Inohara, Yasunori Ogura
-
Publication number: 20060105413Abstract: The present invention related to methods and compositions for modulating cellular signaling. In particular, the present invention relates to PKK and RICK3 proteins. The present invention further relates the to use of PKK and RICK3 proteins in modulating NF-?B signaling. The present invention thus provides novel targets for drug screening and therapeutics.Type: ApplicationFiled: December 22, 2005Publication date: May 18, 2006Inventors: Gabriel Nunez, Naohiro Inohara, Akihiro Muto
-
Patent number: 7041491Abstract: The present invention relates to the NOD proteins and nucleic acids encoding the NOD proteins. The present invention further provides assays for the detection of NOD polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NOD proteins.Type: GrantFiled: March 5, 2004Date of Patent: May 9, 2006Assignee: Regents of the University of MichiganInventors: Naohiro Inohara, Gabriel Nuñez
-
Publication number: 20050239105Abstract: The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, methods for the detection of Nod2, and methods for screening compounds for the ability to alter Nod2 associated signal transduction.Type: ApplicationFiled: November 9, 2004Publication date: October 27, 2005Inventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura
-
Patent number: 6858391Abstract: The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, methods for the detection of Nod2, and methods for screening compounds for the ability to alter Nod2 associated signal transduction. The present invention also provides Nod2 variant alleles. The present invention further provides methods of identifying individuals at increased risk of developing Crohn's disease.Type: GrantFiled: October 26, 2001Date of Patent: February 22, 2005Assignee: Regents of the University of MichiganInventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura, Judy Cho, Dan L. Nicolae, Denise Bonen
-
Publication number: 20050009065Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod1 protein. The present invention provides methods of identifying modulators of Nod1 signaling. The present invention further provides methods of altering Nod1 signaling.Type: ApplicationFiled: May 14, 2004Publication date: January 13, 2005Applicant: The Regents of the University of MichiganInventors: Gabriel Nunez, Naohiro Inohara
-
Patent number: 6835815Abstract: The present invention relates to intracellular signalling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2, isolated Nod2 peptides, antibodies that specifically bind Nod2, methods for the detection of Nod2, and methods for screening compounds for the ability to alter Nod2 associated signal transduction.Type: GrantFiled: October 26, 2001Date of Patent: December 28, 2004Assignee: Regents of the University of MichiganInventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura
-
Publication number: 20040253615Abstract: The present invention relates to the NOD proteins and nucleic acids encoding the NOD proteins. The present invention further provides assays for the detection of NOD polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NOD proteins.Type: ApplicationFiled: March 5, 2004Publication date: December 16, 2004Inventors: Naohiro Inohara, Gabriel Nunez
-
Publication number: 20030199462Abstract: The present invention related to methods and compositions for modulating cellular signaling. In particular, the present invention relates to PKK and RICK3 proteins. The present invention further relates the to use of PKK and RICK3 proteins in modulating NF-&kgr;B signaling. The present invention thus provides novel targets for drug screening and therapeutics.Type: ApplicationFiled: April 23, 2002Publication date: October 23, 2003Inventors: Gabriel Nunez, Naohiro Inohara, Akihiro Muto
-
Publication number: 20030175762Abstract: The present invention relates to intracellular signaling molecules, in particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides methods of identifying modulators of Nod2 signaling. In particular, the present invention additionally provides methods of screening immune modulators such as adjuvants using Nod2. The present invention further provides methods of altering Nod2 signaling.Type: ApplicationFiled: December 9, 2002Publication date: September 18, 2003Applicant: The Regents of the University of MichiganInventors: Gabriel Nunez, Naohiro Inohara, Yasunori Ogura